Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Curt

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Diabetes Care|September 1, 1982
Reversible acute pulmonary edema due to uncontrolled hyperglycemia in diabetic individuals with renal failureA Kaldany, G A Curt, N M Estes, et al.
Investigational New Drugs|January 1, 1986
Skin reactions induced by trimetrexate, an analog of methotrexateR B Weiss, W D James, W B Major, et al.
Annals of Internal Medicine|January 1, 1980
Reversible rapidly progressive renal failure with nephrotic syndrome due to fenoprofen calciumG A Curt, A Kaldany, L G Whitley, et al.
Cancer Research|October 15, 1988
Phase I and clinical pharmacology study of intravenous flavone acetic acid (NSC 347512)R B Weiss, R F Greene, R D Knight, et al.
The Journal of Clinical Investigation|October 1, 1985
Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexateG A Curt, J Jolivet, D N Carney, et al.
Investigational New Drugs|May 1, 1990
A phase I and pharmacokinetic study of trimetrexate using a 24-hour continuous-injection scheduleC J Allegra, J Jenkins, R B Weiss, et al.
The Journal of Clinical Investigation|September 1, 1985
Polyglutamation of methotrexate. Is methotrexate a prodrug?B A Chabner, C J Allegra, G A Curt, et al.
Cancer Research|December 1, 1983
Phase II and pharmacokinetic study of aziridinylbenzoquinone [2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, diaziquone, NSC 182986] in high-grade gliomasG A Curt, J A Kelley, C V Kufta, et al.
Cancer Research|July 1, 1985
A phase I and pharmacokinetic study of dihydro-5-azacytidine (NSC 264880)G A Curt, J A Kelley, R L Fine, et al.
Cancer Research|September 1, 1983
A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240)G A Curt, J J Grygiel, B J Corden, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Diabetes Care|September 1, 1982
Reversible acute pulmonary edema due to uncontrolled hyperglycemia in diabetic individuals with renal failureA Kaldany, G A Curt, N M Estes, et al.
Investigational New Drugs|January 1, 1986
Skin reactions induced by trimetrexate, an analog of methotrexateR B Weiss, W D James, W B Major, et al.
Annals of Internal Medicine|January 1, 1980
Reversible rapidly progressive renal failure with nephrotic syndrome due to fenoprofen calciumG A Curt, A Kaldany, L G Whitley, et al.
Cancer Research|October 15, 1988
Phase I and clinical pharmacology study of intravenous flavone acetic acid (NSC 347512)R B Weiss, R F Greene, R D Knight, et al.
The Journal of Clinical Investigation|October 1, 1985
Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexateG A Curt, J Jolivet, D N Carney, et al.
Investigational New Drugs|May 1, 1990
A phase I and pharmacokinetic study of trimetrexate using a 24-hour continuous-injection scheduleC J Allegra, J Jenkins, R B Weiss, et al.
The Journal of Clinical Investigation|September 1, 1985
Polyglutamation of methotrexate. Is methotrexate a prodrug?B A Chabner, C J Allegra, G A Curt, et al.
Cancer Research|December 1, 1983
Phase II and pharmacokinetic study of aziridinylbenzoquinone [2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, diaziquone, NSC 182986] in high-grade gliomasG A Curt, J A Kelley, C V Kufta, et al.
Cancer Research|July 1, 1985
A phase I and pharmacokinetic study of dihydro-5-azacytidine (NSC 264880)G A Curt, J A Kelley, R L Fine, et al.
Cancer Research|September 1, 1983
A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240)G A Curt, J J Grygiel, B J Corden, et al.
Pageof 5